Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2005 1
2006 1
2007 1
2008 2
2010 2
2012 1
2013 1
2014 3
2015 2
2016 7
2017 3
2018 4
2019 5
2020 1
2021 3
2022 4
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Ru(III) Complexes with Lonidamine-Modified Ligands.
Shutkov IA, Okulova YN, Tyurin VY, Sokolova EV, Babkov DA, Spasov AA, Gracheva YA, Schmidt C, Kirsanov KI, Shtil AA, Redkozubova OM, Shevtsova EF, Milaeva ER, Ott I, Nazarov AA. Shutkov IA, et al. Among authors: shevtsova ef. Int J Mol Sci. 2021 Dec 15;22(24):13468. doi: 10.3390/ijms222413468. Int J Mol Sci. 2021. PMID: 34948263 Free PMC article.
New Hybrid Structures Based on Memanthine and Edaravone Molecules.
Grigoriev VV, Shevtsova EF, Aksinenko AY, Veselov IM, Goreva TV, Gabrelyan AV, Bachurin SO. Grigoriev VV, et al. Among authors: shevtsova ef. Dokl Biochem Biophys. 2023 Oct;512(1):284-287. doi: 10.1134/S1607672923700461. Epub 2023 Dec 13. Dokl Biochem Biophys. 2023. PMID: 38093132
Securinine Derivatives as Potential Anti-amyloid Therapeutic Approach.
Neganova ME, Klochkov SG, Petrova LN, Shevtsova EF, Afanasieva SV, Chudinova ES, Fisenko VP, Bachurin SO, Barreto GE, Aliev G. Neganova ME, et al. Among authors: shevtsova ef. CNS Neurol Disord Drug Targets. 2017;16(3):351-355. doi: 10.2174/1871527315666161107090525. CNS Neurol Disord Drug Targets. 2017. PMID: 27823572
Overview of novel multifunctional agents based on conjugates of γ-carbolines, carbazoles, tetrahydrocarbazoles, phenothiazines, and aminoadamantanes for treatment of Alzheimer's disease.
Makhaeva GF, Shevtsova EF, Boltneva NP, Lushchekina SV, Kovaleva NV, Rudakova EV, Bachurin SO, Richardson RJ. Makhaeva GF, et al. Among authors: shevtsova ef. Chem Biol Interact. 2019 Aug 1;308:224-234. doi: 10.1016/j.cbi.2019.05.020. Epub 2019 May 14. Chem Biol Interact. 2019. PMID: 31100279 Review.
New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments.
Lapshina MA, Shevtsova EF, Grigoriev VV, Aksinenko AY, Ustyugov AA, Steinberg DA, Maleev GV, Dubrovskaya ES, Goreva TV, Epishina TA, Zamoyski VL, Makhaeva GF, Fisenko VP, Veselov IM, Vinogradova DV, Bachurin SO. Lapshina MA, et al. Among authors: shevtsova ef. Molecules. 2023 Nov 13;28(22):7567. doi: 10.3390/molecules28227567. Molecules. 2023. PMID: 38005288 Free PMC article.
44 results